TWI224005B - Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same - Google Patents
Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same Download PDFInfo
- Publication number
- TWI224005B TWI224005B TW87114505A TW87114505A TWI224005B TW I224005 B TWI224005 B TW I224005B TW 87114505 A TW87114505 A TW 87114505A TW 87114505 A TW87114505 A TW 87114505A TW I224005 B TWI224005 B TW I224005B
- Authority
- TW
- Taiwan
- Prior art keywords
- fever
- item
- nasal
- patent application
- scope
- Prior art date
Links
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 42
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 16
- 239000007922 nasal spray Substances 0.000 title abstract description 32
- 229940097496 nasal spray Drugs 0.000 title abstract description 31
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 19
- 239000007921 spray Substances 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 9
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 9
- 239000011718 vitamin C Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 52
- 229940079593 drug Drugs 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 229940100656 nasal solution Drugs 0.000 claims description 11
- 239000000341 volatile oil Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 8
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 229940097275 indigo Drugs 0.000 claims description 5
- 241000510654 Bupleurum chinense Species 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 241000334160 Isatis Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003640 drug residue Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- -1 road Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- 244000180419 Brassica nigra Species 0.000 claims description 2
- 235000011291 Brassica nigra Nutrition 0.000 claims description 2
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229940124277 aminobutyric acid Drugs 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 230000000762 glandular Effects 0.000 claims description 2
- 235000003642 hunger Nutrition 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- CRDNMYFJWFXOCH-UHFFFAOYSA-N indirubin Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 241000202726 Bupleurum Species 0.000 claims 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 2
- 229950005143 sitosterol Drugs 0.000 claims 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 claims 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 235000009697 arginine Nutrition 0.000 claims 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims 1
- 229910003460 diamond Inorganic materials 0.000 claims 1
- 239000010432 diamond Substances 0.000 claims 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 1
- 239000010977 jade Substances 0.000 claims 1
- 235000014666 liquid concentrate Nutrition 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- 235000013930 proline Nutrition 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims 1
- 235000015500 sitosterol Nutrition 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 210000001331 nose Anatomy 0.000 abstract description 10
- 239000010231 banlangen Substances 0.000 abstract description 9
- 210000003928 nasal cavity Anatomy 0.000 abstract description 9
- 206010019233 Headaches Diseases 0.000 abstract description 7
- 231100000869 headache Toxicity 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 241000213015 Bupleurum scorzonerifolium Species 0.000 abstract description 5
- 206010011224 Cough Diseases 0.000 abstract description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 5
- 201000007100 Pharyngitis Diseases 0.000 abstract description 5
- 206010028735 Nasal congestion Diseases 0.000 abstract description 4
- 206010049590 Upper respiratory tract inflammation Diseases 0.000 abstract description 3
- 239000012528 membrane Substances 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 206010041232 sneezing Diseases 0.000 abstract description 2
- 238000004821 distillation Methods 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 239000006196 drop Substances 0.000 description 31
- 230000001754 anti-pyretic effect Effects 0.000 description 22
- 230000000694 effects Effects 0.000 description 22
- 239000002221 antipyretic Substances 0.000 description 15
- 241000700159 Rattus Species 0.000 description 14
- 201000009240 nasopharyngitis Diseases 0.000 description 10
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940072651 tylenol Drugs 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 208000012287 Prolapse Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 239000007928 intraperitoneal injection Substances 0.000 description 5
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 5
- 229940098462 oral drops Drugs 0.000 description 5
- 210000003800 pharynx Anatomy 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 210000002850 nasal mucosa Anatomy 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010013082 Discomfort Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 241000334154 Isatis tinctoria Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000002110 toxicologic effect Effects 0.000 description 3
- 231100000027 toxicology Toxicity 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000007575 Calluna vulgaris Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- VLXDPFLIRFYIME-GZBLMMOJSA-N Copaene Natural products C1C=C(C)[C@H]2[C@]3(C)CC[C@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-GZBLMMOJSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010061192 Haemorrhagic fever Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- MVZZUMCHPFHUOS-UHFFFAOYSA-N Patchoulane Chemical compound CC1CCC(C2(C)C)CC3C12CCC3C MVZZUMCHPFHUOS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 206010043521 Throat irritation Diseases 0.000 description 2
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- PFXFABJPDNHACA-UHFFFAOYSA-N alpha-copaene Natural products CC(C)C1C2CC(=CCC2C3(C)CC13)C PFXFABJPDNHACA-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940125716 antipyretic agent Drugs 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- VLXDPFLIRFYIME-BTFPBAQTSA-N copaene Chemical compound C1C=C(C)[C@H]2[C@]3(C)CC[C@@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-BTFPBAQTSA-N 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000007923 nasal drop Substances 0.000 description 2
- 229940100662 nasal drops Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- ITYNGVSTWVVPIC-DHGKCCLASA-N (-)-allo-Aromadendrene Chemical compound C([C@@H]1[C@H]2C1(C)C)CC(=C)[C@@H]1[C@H]2[C@H](C)CC1 ITYNGVSTWVVPIC-DHGKCCLASA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CXENHBSYCFFKJS-VDQVFBMKSA-N (E,E)-alpha-farnesene Chemical compound CC(C)=CCC\C(C)=C\C\C=C(/C)C=C CXENHBSYCFFKJS-VDQVFBMKSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- OEZJLUBWUDVTSS-UHFFFAOYSA-N 2-chloro-1,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C([N+]([O-])=O)C(Cl)=C1 OEZJLUBWUDVTSS-UHFFFAOYSA-N 0.000 description 1
- WPRSYXIOJJRNKW-UHFFFAOYSA-N 2-hydroxybut-3-enyl thiocyanate Chemical compound C=CC(O)CSC#N WPRSYXIOJJRNKW-UHFFFAOYSA-N 0.000 description 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- HMFHBZSHGGEWLO-IOVATXLUSA-N D-xylofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-IOVATXLUSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920004142 LEXAN™ Polymers 0.000 description 1
- AYXPYQRXGNDJFU-AOWZIMASSA-N Ledol Chemical compound [C@@H]1([C@](CC[C@@H]2[C@H]3C2(C)C)(C)O)[C@H]3[C@H](C)CC1 AYXPYQRXGNDJFU-AOWZIMASSA-N 0.000 description 1
- CKZXONNJVHXSQM-UHFFFAOYSA-N Ledol Natural products CC(C)C1CCC(C)(O)C2C3CC(C)CC123 CKZXONNJVHXSQM-UHFFFAOYSA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 239000004418 Lexan Substances 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010068956 Respiratory tract inflammation Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- KEIZXGINFPDITQ-UHFFFAOYSA-N UNPD138008 Natural products C1=C(O)C(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)C(C)O3)O)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 KEIZXGINFPDITQ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- UIDUJXXQMGYOIN-UHFFFAOYSA-N aromadendrin Natural products CC1(C)C2C1CCC(C)C1C2C(C)CC1 UIDUJXXQMGYOIN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000035565 breathing frequency Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- UIDGLYUNOUKLBM-GEBJFKNCSA-N isorhamnetin-3-O-rutinoside Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)O2)O)=C1 UIDGLYUNOUKLBM-GEBJFKNCSA-N 0.000 description 1
- BGLPQQKZNUKSAR-UHFFFAOYSA-N isorhamnetin-3-O-rutinoside Natural products COc1ccc(cc1O)C2=C(OC3OC(COCC4OC(O)C(O)C(O)C4O)C(O)C(O)C3O)C(=O)c5c(O)cc(O)cc5O2 BGLPQQKZNUKSAR-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- IEPKWJCBNGNVDF-UHFFFAOYSA-N narcissin Natural products OC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(O)C(O)C(COC3C(C(O)C(O)C(C)O3)O)O2)O)=C1 IEPKWJCBNGNVDF-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- PCZXEAAHGUQDNV-XBNKRBCZSA-N tetrahymanol Natural products CC1(C)CC[C@]2(C)CC[C@]3(C)[C@H]4CC[C@H]5[C@@H](CC[C@H](O)C5(C)C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1 PCZXEAAHGUQDNV-XBNKRBCZSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
1224005 九、發明說明: 【發明所屬之技術領域】 本發明係有關一種發燒感冒喷(滴)鼻液劑之醫藥組成物及其 ‘法,將该狹葉柴胡(Bupleurum Scorzonerifolium Willd)、板 藍根(Radix Isatidis Indigotica)、大青葉(Folium Isatidis)以 烈煮後並以提取及濾出藥液之方式,將所含之成分提取及濾出 後,再將此藥液與維生素C混合製成藥劑,使製成之藥劑可供患者 直接喷(滴)至鼻腔内部,由鼻腔粘膜吸收後,具有退燒解熱、鎮 痛、緩解感冒症狀’如頭痛、鼻塞、咳漱、咽喉痛、喷嗓、流洋 及全身不適等感冒症狀之功效,也適用於各種感染性疾病引起之 發燒,尤其以上呼吸道炎症更為適宜。 【先前技術】 感冒,一般人多認為是微不足道之病症,其實,感冒是一種 傳染力很強的病毒性傳染病。其特徵為一組可以識別的常見徵狀 一倦怠、發熱、流淚、鼻塞、頭痛、咽喉乾燥或疼痛。許多病毒 都可以引起感冒。感冒病毒十分微小,可以輕易通過鼻道中的過 濾網,溜進人體,這個過濾網通常只能捕捉體積較大細菌。病毒 迅速增殖,侵害鼻和咽喉,引起常見感冒徵狀。有時會引起併發 症如肺炎或支氣管炎。若是處理不當,甚至會致死。事實上,感 冒是一種不可忽視的常見疾病。 治療感冒在西醫治療方面,不外乎服用抗生素退燒、類固醇 緩解鼻基、抗組織胺等緩解感冒症狀,再加上多喝水、多休息。 1224005 -般而言西賴效比較迅速確實,但抗生素所產生的抗藥性,類 固醇對人體傷害的毒性,化學物質對人體臟器的損害都是現代人 們所熟知的不良作用。而且上述化學藥物對於發燒感冒的缓解、 預防也不盡理想。化賴、感胃藥物在劑型方面—般常用的有膠 囊、綻劑、栓劑、口服液、鼻喷(滴)劑。 感冒的防治在巾醫藥方面,—般由解表藥為主組成 ,以發汗 為主’達到疏散外邪。用以解除表證的方劑,統稱為解表劑。解 表方藥的功效主要有三方面,⑴發汗,通過發汗可_表之邪, 發汗還可以防止病邪傳裏;⑵解肌,解肌是指邪已深入一層,汗 雖出而表證未解,須用疏通肌表,解除肌表之邪;⑶透療,解表 方藥中有些㈣導賴向表’促使贿透發,由於外邪有寒熱之 分’人體有虛症和實症之別’故解刻又分為辛溫解表(用於外感 風寒表證)’辛涼解表(用於外感風熱表證)和扶正解表(用於體質 素虛又感外邪而引起的表證)三大類。中草藥製劑方面常用中藥有 私^ /野(液)劑為主。它有使用安全、副作用小的伽;但有藥 效緩慢,使用不便的缺點。 退燒祛熱方面,除了化學藥物和中草_有不同程度的效果 外尚有物理降溫··如冰敷、酒精擦浴、冰水灌腸等等方法。儘 ^上述方法在臨床上也有—定效果,但也有不纽床病例使用上 ^方法後’體溫非但不降,反而有上升的趨勢。其中冰敷與酒精 务理降溫,因病人高熱絲,難以接受,而且使職不方便。 1224005 综觀上述巾、西㈣醫治發燒、感胃、退祕理治療,不論 西藥、帽或物珊溫,每種綠都存在料完善缺點。 【發明内容】 如果有-種能迅速退燒、緩解感胃症狀、無副伽而且又使 用方便、男女老少都可適㈣退燒感胃製劑,聊是-個非常有 意義的伽。本發明主要特色能有效溶合中、西感f藥和物理退 燒的全部優點於-體而去除全部缝,謂人類應是财意義的 發明。 本發明是以純祕藥粒,組織有效成份,將能迅速退燒、 緩解感冒的藥液製成鼻喷劑。再利用人體生理、器官的特點,從 鼻腔粘膜給藥,避開藥物受腸胃P h值或酶的破壞,直接由鼻腔 粘膜吸收,避免藥效經口服時受肝臟首過作用的破壞,可以減少 藥物對肝臟的毒性及副作用。以達到具有迅速退燒、緩解感冒各 種症狀,女全平無副作用、使用方便,男女老幼皆適用,且攜帶 方便的天然植物藥製成退燒、緩解感冒的鼻喷劑。而且在劑型方 面’嘴(滴)劑對於不能或吞服物困難的患者或兒童尤其方便。 本發明之發燒感冒喷鼻液(滴)劑之醫藥組成物包括: 狹葉柴胡(Bupleurum Scorzonerifolium Willd)、板藍根(Radix Isatidis Indigotica)、大青葉(Folium Isatidis)及維生素C, 將前述之醫藥組成物提取製成藥劑後,藉以噴(滴)至鼻腔,由鼻 腔钻膜吸收,以達到退燒解熱、鎮痛、緩解感冒症狀,如頭痛、 鼻塞、咳嗽、咽喉痛、喷嚏、流涕及全身不適等感冒症狀之功效, 7 1224005 也適用於各誠引起之發練,尤其社呼吸道炎症更1224005 IX. Description of the invention: [Technical field to which the invention belongs] The present invention relates to a pharmaceutical composition for fever and cold spray (drop) nasal solution and its method, the Bupleurum Scorzonerifolium Willd, Banlangen ( Radix Isatidis Indigotica) and Folium Isatidis are used to extract and filter out the ingredients after they are boiled and extracted and filtered out, and then this medicine is mixed with vitamin C to make a medicament. The prepared medicine can be sprayed (dropped) directly into the inside of the nasal cavity by the patient. After absorption by the nasal mucosa, it has antipyretic, antipyretic, analgesic, and relief of cold symptoms such as headache, nasal congestion, cough, sore throat, spit throat, fluent and The effects of cold symptoms such as general discomfort are also applicable to fever caused by various infectious diseases, especially the upper respiratory tract inflammation is more suitable. [Previous technology] Colds are generally considered to be insignificant. In fact, colds are a highly contagious viral infectious disease. It is characterized by a common set of recognizable symptoms-burnout, fever, tearing, stuffy nose, headache, dry throat or pain. Many viruses can cause a cold. The cold virus is very small and can easily slip into the body through a filter in the nasal passage. This filter usually only catches large bacteria. The virus multiplies quickly, invades the nose and throat, and causes common cold symptoms. Sometimes it can cause complications such as pneumonia or bronchitis. If not handled properly, it can even cause death. In fact, colds are a common disease that cannot be ignored. Treating colds In terms of Western medicine treatment, it is nothing more than taking antibiotics to reduce fever, steroids to relieve nasal, antihistamines, etc. to alleviate cold symptoms, plus drink plenty of water and rest. 1224005-In general, the effects of cisicide are relatively rapid and accurate, but the resistance caused by antibiotics, the toxicity of steroids to humans, and the damage to human organs caused by chemicals are all adverse effects known to modern people. In addition, the above-mentioned chemical drugs are not ideal for the relief and prevention of fever and cold. In terms of dosage forms, the drugs that rely on the stomach and the stomach are commonly used in capsules, creams, suppositories, oral liquids, and nasal sprays. For the prevention and cure of colds, in the field of towel medicine, it is generally composed mainly of antihypertensive drugs, and mainly sweating to achieve evacuation. The prescriptions used to relieve the card are collectively referred to as anti-table drugs. There are three main effects of the formula for relieving the epidemic. Sweating can be achieved through sweating. The sweat can also prevent the spread of disease and evil; dissolving the muscles and demystifying means that the evil has gone deeper. Although the sweat is out, the evidence is not resolved. It is necessary to use to clear the muscle surface to relieve the evil of the muscle surface; ⑶ In the treatment, some of the prescriptions for relieving the skin relied on the table to promote the bribery, because of the cold and heat of external evils, the body has the difference between deficiency and actual disease. Therefore, the interpretation is divided into Xin Wen solution table (for exogenous wind and cold table certificate) 'Xin Liang solution table (for exogenous wind and heat table certificate) and Fuzheng solution table (for physique deficiency and external evil caused table Card) three categories. Chinese herbal medicines are commonly used in traditional Chinese medicines. It is safe to use and has low side effects; however, it has the disadvantages of slow efficacy and inconvenient use. In terms of antipyretic and antipyretic, in addition to the effects of chemical drugs and Chinese herbal medicines, there are also physical cooling methods such as ice compresses, alcohol rubbing baths, and ice water enema. As far as possible, the above-mentioned method also has a certain effect in clinical practice, but there are also cases where the button is not used. After using the method, the body temperature will not decrease, but will increase. Among them, ice compress and alcohol are used to cool down, because the patient's high-temperature wire is difficult to accept, and it is inconvenient to work. 1224005 Looking at the above towels, Xiqiao for fever, stomach sensation, and ecstasy treatment, no matter there is western medicine, cap, or material, each kind of green has the disadvantages of perfect materials. [Summary of the Invention] If there is a kind of preparation that can quickly reduce fever, alleviate the symptoms of gastric sensation, have no paragamma and is convenient to use, and can be used for men, women, and children, it can be used to reduce fever and stomach. The main feature of the present invention is that it can effectively dissolve all the advantages of Chinese and Western medicines and physical antipyretics in one body and remove all seams, which means that human beings should be inventions of financial significance. The present invention is a nasal spray made of pure secret medicine granules and effective components of tissues, which is a medicine solution capable of rapidly reducing fever and alleviating colds. Reusing the characteristics of the human physiology and organs, administering from the nasal mucosa, avoiding the damage of the drug by the gastrointestinal pH value or enzymes, and directly absorbing it from the nasal mucosa, avoiding the effect of the medicine being damaged by the first pass of the liver when taken orally. Toxicity and side effects of the drug on the liver. In order to achieve a rapid fever, alleviate the symptoms of colds, female all-ping has no side effects, easy to use, suitable for men, women and children, and carry convenient natural plant medicines to make fever and relieve cold nose spray. In addition, in the form of a dosage form, the mouth (drop) is particularly convenient for patients or children who cannot or cannot swallow. The pharmaceutical composition of the fever and cold nasal spray (drops) of the present invention includes: Bupleurum Scorzonerifolium Willd, Radix Isatidis Indigotica, Folium Isatidis, and Vitamin C. The aforementioned medicine is composed of After the extract is made into a medicament, it is sprayed (dropped) into the nasal cavity and absorbed by the nasal drill film to achieve fever, antipyretics, analgesia, and relief of cold symptoms, such as headache, nasal congestion, cough, sore throat, sneezing, runny nose, and general discomfort. The efficacy of cold symptoms, 7 1224005 is also suitable for hair training caused by various causes, especially the respiratory tract inflammation.
月經不調’氣虛下陷之脫肛,子宮脫垂,胃下垂。 本發明之醫藥組成物之板藍根(Radix Isatidis lndig〇tica) 斑,高熱頭痛,大頭 水痘,麻療,肝炎, 具有清熱,解毒,涼血,利咽。主治溫毒發斑, 痕疫,喉丹#,丹毒,痒腿,喉痒,瘡腫,水痛 流行性感冒。 本發明之醫藥、组成物之大青葉⑽iumIsatidis)具有清熱解Irregular menstruation 'prolapse of qi deficiency, prolapse of the uterus, drooping of the stomach. Radix Isatidis lndigotica, a medicinal composition of the present invention, has plaques, high fever, headache, varicella, anesthesia, hepatitis, and has antipyretic, detoxifying, cooling blood, and pharyngeal. Indications Wendu hair spot, scar disease, throat Dan #, erysipelas, itchy legs, itchy throat, sores, water pain influenza. The medicine and composition of the present invention (Isatidis)
本發明之醫藥組成物之維生素C具有預防感冒,增強抵抗 力,減輕感冒症狀。主治濾過性病原體所引起之感冒。 係有關本發明之詳細說明及技術内容,現配合圖表說明如下: 【實施方式】 請參閱「圖1所示」,係本發明之發燒感冒鼻喷(滴)劑之製作 流程示意圖。如圖所示:本發明之發燒感冒喷鼻液(滴)劑之醫藥 組成物及其製法,而該醫藥組成物包括:25〇〜3〇〇§狹葉柴胡 (Bupleurum Scorzonerifolium Willd)、120〜144g板藍根(Radix Isatidis Indigotica)、12G〜144g大青葉(Folium isatidis)& 8 1^24005 10 12g維生素C ’將别述之醫藥組成物提取製成藥劑後,藉以喷 或用滴至鼻L内膜’自鼻脚罐吸收,可達到退燒解熱、鎮痛、 緩解感冒症狀,如·、鼻塞、铺、咽喉痛、対、流洋及全 身不適等感W症狀功效,亦適驗各贼染性疾病狀之發燒, 尤其以上呼吸道炎症效果更佳。 而上述各醫藥組成物所含之化學成份及藥理方面與功能及主 治上,都具有娜醫療效果,本發縣各醫餘成物分別說明如 下: 1、狹葉柴胡(Bupleurum Scorzonerifolium Willd) 【化學成份】 狹葉柴胡之根含揮發油,該揮發油内含有松油烯(冷 -terpinene)、擰檬烯、樟烯(camphene)、卢—小茴香稀(冷 -fenchene)、胡薄荷酮、異龍腦(is〇b〇rne〇i)、沒―松油醇(冷 -terpineol)、芳樟醇、α —珀圯烯(α—copaene)、葎草烯、^ 金合歡烯(a-farnesene)、香燈烯(aromadendrene)、順式的和反 式的丁香烯、yS -欖香烯(点-elemene)、r 一衣藍油烯(7 -muurolene)、廣藿香烷(patchoulane)、努特卡花柏嗣、制叭醇 (ledol)。又含柴胡總式〇·ΐ5%,其中柴胡皂式a〇.05%、柴胡急 式d微量、柴胡皂武c〇·跳。地上部分含黃酮類化合物:山索 式、山柰紛-7-鼠李糖式、槲皮素(quercetirO、異榭皮素 (isoquercetin)、異鼠李素(isorhamnetin)、芸香武(rutin)、 9 !224〇〇5 水仙(narcissin)。 【藥理方面】 有鎮痛作用,以小鼠壓尾法或醋酸扭體法均證明了口服$胡 粗皂式有_的鎮痛侧。用t擊鼠尾法實驗,證實柴胡息式 478mg/kg(l/4LD50)能使痛閾明顯增高。柴胡粗息武元a與糖 殘餘物腹腔注射50mg/kg或l〇Gmg/kg均能抑制小鼠腹腔注射= 引起的減反應,糖餘雜物職迫法所鱗財鶴鎮痛^ 用。有人認為_皂也可通過鬆弛平滑崎張秘揮鎮痛作用。 有鎮咳作用,柴胡總皂式及柴胡粗皂式元轉缝__ 用’機械舰射紐明,豚鼠腹驗射總皂式触的_為 9· ling/kg ’其效果與魏可待因7. 6 mg/kg相近。柴胡粗阜式元a 的鎮咳作用與劑量有關’豚鼠腹腔注射⑽~2()()mg/kg鎮咳作用最 明顯。 、 【功能與主治】 —具有解表退熱’疏肝解郁,升舉陽氣。崎主治外感發熱, 寒熱往來,雜,肝㈣魏脹頭痛職,月經不調,氣虛下陷 之脫肛,子宮脫垂,胃下垂。 2、板藍根(Radix isatidis Indig〇tica) 【化學成份】 板監根根含憾Gnchgotin,indig〇),款玉紅(祕耐小 /5谷田醇(万-讲⑽的丨)、r 谷留醇(卜5丨t〇ster〇丨)以及多種氨基 1224005 酸:精氨酸(arginine)、谷氨酸(glutamic acid)、赂氨酸 (tyrosine)、脯氨酸(proline)、纈氨酸(valine)、τ-氨基丁酸 (r -aminobutyric ack〇、還含黑芥子式(sinigrin)、彀武 (indoxy卜/5-glucoside),色氨銅(tryptanthrine),l-硫氰酸一2— 輕基丁 -3-烯(1-thiocyano-2-hydroxy-3-butene)、表告伊春The vitamin C of the medicinal composition of the present invention has the functions of preventing colds, enhancing resistance, and alleviating cold symptoms. Indications for colds caused by filtered pathogens. It is related to the detailed description and technical content of the present invention, and is illustrated with the following chart: [Embodiment] Please refer to "shown in Fig. 1", which is a schematic diagram of the manufacturing process of the fever and cold nasal spray (drop) of the present invention. As shown in the figure: the pharmaceutical composition of the fever and cold nasal spray (drops) of the present invention and the preparation method thereof, and the pharmaceutical composition includes: 25 ~ 3〇§Bupleurum Scorzonerifolium Willd, 120 ~ 144g Radix Isatidis Indigotica, 12G ~ 144g Folium isatidis & 8 1 ^ 24005 10 12g Vitamin C 'After extracting the other pharmaceutical composition into a medicament, spray or use it to the nose Endometrium is absorbed from the nose and foot tank, which can achieve antipyretic, antipyretic, analgesic, and alleviate cold symptoms, such as ..., nasal congestion, sputum, sore throat, dysentery, flowing ocean, and general discomfort. It also has symptoms and effects. Symptoms of fever, especially the upper respiratory tract inflammation are better. The chemical components, pharmacological aspects, functions, and indications contained in each of the above medicinal compositions have medical effects. Each of the medical surplus products in Benfa County are described as follows: 1. Bupleurum Scorzonerifolium Willd [ Chemical composition] The root of Bupleurum chinense contains volatile oil, which contains terpinene, limonene, camphene, camphene, cold-fenchene, menthol, allosaurus Brain (is〇b〇rne〇i), terpineol (cold-terpineol), linalool, α-copaene (α-copaene), humulene, a-farnesene Aromadendrene, cis and trans syringene, yS-elemene, r-muurolene, patchoulane, nut Teka flower cypress, ledol. It also contains Chaihu total formula 0.5%, of which Chaihu soap type a0.05%, Chaihu urgent formula d trace amount, Chaihu soap Wu c0. Jump. The above-ground part contains flavonoids: mountain cable type, mountain tree 7-rhamnoside, quercetirO, isoquercetin, isorhamnetin, rutin, 9! 224〇05 narcissin. [Pharmacological aspect] It has analgesic effect. Both mouse tail pressing method and acetic acid writhing method have proved the oral analgesic side of the glutinous soap. The experiment showed that Chaihu Xi formula 478mg / kg (l / 4LD50) can significantly increase the pain threshold. Chaihu crude Wuyuan a and sugar residue intraperitoneal injection of 50mg / kg or 10Gmg / kg can inhibit mice Intraperitoneal injection = reduced reaction caused by sugar residues and sclerosing method of scales and cranes analgesic ^. Some people think that _ soap can also relax and smoothen the analgesic effect by relaxing and smoothing. It has an antitussive effect, Chaihu total soap type and Chai Hu rough soap type joints __ with 'mechanical ship fired Niu Ming, guinea pig abdominal examination total soap touch _ is 9 · ling / kg', the effect is similar to Wei codeine 7.6 mg / kg. Chai The antitussive effect of Hu fufuyuan a is related to the dose. 'Guina pig intraperitoneal injection of ⑽ ~ 2 () () mg / kg has the most obvious antitussive effect. [Function and indications] — with solution Relieve fever and relieve stagnation of the liver, lift yang qi. Qi is responsible for exogenous fever, cold and heat, miscellaneous, liver, bloating and headache, irregular menstruation, prolapse of qi due to qi deficiency, prolapse of the uterus, stomach prolapse. 2. Radix isatidis Indig〇tica) [Chemical composition] Roots of Banjian Roots contain regrets Gnchgotin, indig〇), Yuhong (Mianxiao Xiao / 5 Gutian alcohol (million-speaking 丨), r glutanol (b 5 丨 t〇 ster〇 丨) and various amino 1224005 acids: arginine, glutamic acid, tyrosine, proline, valine, τ-aminobutyric acid Acid (r-aminobutyric ack〇, also contains black mustard (sinigrin), indoxy (/ 5-glucoside), tryptanthrine, l-thiocyanate 2-light-butan-3-ene (1-thiocyano-2-hydroxy-3-butene), report to Yichun
CepigoitrirO、腺式Udenosine}、棕櫚酸(palmitic acid}、蔗 , 糖(sucrose)和含有12%氨基酸的蛋白多糖。CepigoitrirO, glandular Udenosine}, palmitic acid, sucrose, sucrose, and proteoglycan containing 12% amino acids.
【藥理方面】 I 有抗細菌、病毒作用,在體外試驗,1〇〇%板藍根水煎液對金 頁色葡萄球菌,表皮葡萄球菌有抑菌作用。單層乂沈〇—耶的細胞用 50〇/〇組織細胞感染量(TCID5〇)出血熱病毒吸附,板藍根注射液做抗 病毒實驗,結果1:1〇〇板藍根對腎病綜合征出血熱病毒有明 顯的殺滅作用。板藍根抽提物能抑制病毒侵染并有抑制增殖作用。 對免疫凋節作用,板藍根多糖25呢/故、50mg/kg、l〇〇mg/kg 腹腔注射可明顯增強小鼠對二硝基氯苯(1^(:幻的遲發型變態反鲁 應’誘導體内淋巴細胞轉化和增強脾細胞的自然殺傷細胞(Νκ)活 吐。腹腔注射板藍根多^5〇 mg/kg可顯著促進小鼠免疫功能,其 表見為此明顯增加正常小鼠脾重,白細胞總數及淋巴細胞數,對 氫化可的鬆職免疫魏抑制小鼠脾指數,自細胞總數及淋巴細 胞數的降低有明顯對抗作用,顯著增強二石肖基氯苯所致正常及環 鱗胺所致免疫抑制顿崎發魏敏反應;糾,還能增強抗體 11 1224005 形成細胞功能,增加小鼠靜注碳廓清速率。 【功能與主治】 清熱,解毒,涼血,利咽。主治溫毒發斑,高熱顯痛,大頭 瘟疫,喉丹瘀,丹毒,痄腮,喉痒,瘡腫,水痘,麻疼,肝$ 流行性感冒。 3、大青葉(Folium Isatidis) 【化學成份】 葉含靛藍(indigo,indigotin),菘藍式(isat[Pharmacological aspects] I has antibacterial and viral effects. In vitro tests, 100% isatis root water decoction has antibacterial effects on Staphylococcus aureus and Staphylococcus epidermidis. A single layer of Shenyangye cells was adsorbed with hemorrhagic fever virus with a 50/0 histocytosis amount (TCID50). Banlangen injection was used for antiviral experiments. Results: 1: 100 Banlangen has a nephrotic syndrome hemorrhagic fever virus. Obvious killing effect. Isatis root extract can inhibit virus infection and inhibit proliferation. Effect on immune dysfunction, intraperitoneal injection of Isatis indigotica polysaccharides at 25 mg / kg, 50 mg / kg, and 100 mg / kg can significantly enhance p-dinitrochlorobenzene (1 ^ (: phantom delayed allergy reaction) in mice. Induces lymphocyte transformation in vivo and enhances natural killer cell (Nκ) live vomiting of spleen cells. Intraperitoneal injection of Isatis indigotica ^ 50 mg / kg can significantly promote the immune function of mice, which shows that it significantly increases the spleen weight of normal mice. , The total number of white blood cells and the number of lymphocytes, has a significant counteracting effect on the spleen index of hydrocortisone immunosuppressive mice, and has a significant effect on the reduction of the total number of cells and the number of lymphocytes. Causes immunosuppression of Tonzaki Weimin response; correction, can also enhance the formation of antibody 11 1224005 cell function, increase the rate of carbon injection in mice. [Functions and Indications] clearing heat, detoxification, cooling blood, pharyngeal. Spots, high fever, pain, big head plague, throat stasis, erysipelas, cheeks, itching, sore throat, chicken pox, numbness, liver $ influenza. 3. Folium Isatidis [Chemical composition] Leaf contains indigo (Indigo, indigo tin), 菘 蓝 式 (isat
Ldn β),散玉 紅(indirubin)。還含鐵、鈦、錳、鋅、銅以及鈷、鑪 研、碼、絡, 砷等無機元素。菘藍式水解可變為靛藍和呋喃木糖分 (D-xylo-5-hexulofuranosonic acid) 。 y ,酉夂 【藥理方面】 抗病原微生物作用,大青葉煎劑體外試驗對金黃色葡萄球 菌,甲型鏈球菌、腦膜炎雙球菌、肺炎鏈球菌、卡他球菌、傷寒 杆菌、大腸杆菌、流行杆菌、白喉杆菌以及痢疾杆菌均有一定抑 制作用。大青葉對乙型腦炎病毒、月思腺炎病毒、流感病毒等= 抑制作用。此外,大青葉尚有殺滅鉤端螺旋體作用。 【功能與主治】 清熱解毒,涼A消斑。主治瘟熱病高熱煩渴,神昏,斑疹, 土jk 血’ Θ舄痒】·,丹毒,喉痒,口瘡,疗月思。 4、維生素C(維他命C) ί2 1224005 【化學成份】 由碳、氫及氧所組成,分例約為6 : 6。 ‘ 【藥理方面】 預防感冒,感冒的症狀有,發燒、惡寒、全身無力、激烈咳 漱、瘦、鼻塞、頭痛、關節痛等等。感冒大多是因濾過性病原體 . 引起的,所以,身體會虛弱,如果再次受細菌感染,容易引發肺 · 炎、支氣管炎、扁桃腺炎、髓莫炎等嚴重疾病。 【功能與主治】 預防感冒,增強抵抗力,減輕感冒症狀。主治濾過性病原體 所引起之感冒。 再將上述之醫樂組成物,分別以提取及濾、出之方式,將各醫 藥組成物中所含之成份提取及濾出後,再加以混合合併製成,可 供喷(滴)入患者鼻腔粘膜吸收之發燒感冒鼻喷(滴)劑,而製法過 程如下列之步驟: 第一步驟,提取揮發油,將250〜300g狹葉柴胡先用一倍量之馨 水/又/包2小日寸,再加四倍1之水煎煮,以水蒸汽蒸館法,提取揮發 油2ml〜2· 4 W,再濾出藥液1000ml〜1200ml,再將揮發油、濾出液 和藥殘渣分別用容器暫存; 第二步驟,將120〜144g板藍根、120〜144g大青葉分別加入七 倍量的水煎煮1小時後並過濾,將過濾液用容器暫存; 第三步驟,係將第一步驟及第二步驟提取或過濾後所剩餘之 13 1224005 藥殘渣混合後,再加人_紋錢五倍量之水赫〗小時,職 出液^然後加四倍量之水煎煮40分鐘,再滤出液合併;^ 第四步驟,合併上述三份濾、出液,並濃縮到ω藥液相當於以 生樂。再將前述放冷加入95%乙醇到含醇量7〇% ; 第五步驟,縣上述靜體辦,财,时 藥 lg; f六步驟,再胸〜2.4ml揮發油及1()〜12§維生素C,溶解後 加入藥液中,混合過濾後,分裝即得。 上述之醫藥組成物經提取製成噴(滴)鼻劑,細)鼻劑不受 月腸Ph值或酶的破壞,直接從鼻腔誠吸收。不但避免口服時受 :臟首過作用的破壞’而且又可減少藥劑對肝臟的毒性或副作 。樂劑在鼻職膜吸收比π服的預少,伽的時耻一般口 月艮作用快’對雜或吞服藥物_的患者錢童,_鼻給藥較 且在上述各醫藥組成物製成發燒感冒嘴鼻液㈤劑藥劑後, 在解熱作用、毒理研究的實驗上都具妓好效果及安全性,讓窜 用時’可安心使用。而前述所提之解熱作用、毒理研究= 貝驗結果及方法說明如下: 一、噴鼻液(滴)的解熱作用方面: 【實驗材料】 1、噴鼻(滴)劑每含生藥2g, 臨床用藥4為錢每十公斤體重 14 2滴(即約〇· lml),十分鐘内滴完,連用10次,累計用藥量每公斤 體重相當於生藥約〇.2g,實驗前將喷鼻液(滴劑)稀釋,配成所需 的藥物濃度。 2、 安乃近(Analgin)注射液,武漢製藥廠生產,批號9511〇4, 規格〇· 5g/ml,臨床嬰幼兒用20%溶液滴鼻,每次每侧鼻孔卜2滴, 即每次最大用藥量約4〇mg時,嬰幼兒平均體重按1〇kg計算,每公 斤體重給藥制44mg時,實麟將安乃近注射_釋,配成所需 的藥物濃度。 3、 泰諾退熱π服滴液(mEN〇L children S P.s LIQUID), 由美國強生公司生產,批號SGM199,每瓶Ι5πα,每Q.8ml含80mg對 乙我氨基紛(醋氨紛Acetaminophen),臨床按年齡或體重給藥, 每a斤體重-人給藥里約〇· 12mi,即給予乙統氨基酸約121111。 4生理鹽水,河南省平頂山市製藥廠生產,批號讀。 5 ^ l〇W^>S##t^(Themingling ferment liquid for fresh beer),取新鮮啤酒酵母懸液,抽渡,取遽渣用生理鹽水反 覆祕’離心後,棄去上清液,則· 5驗甲基纖維素配成順的濃 度。 6 Wistar大乳,體重m〜·g,由河南醫科大學實驗動物 中心提供。 【方法與結果】 實驗在室溫20〜25 t:鉻彼卞A〆/ 條件下進行(請參閱「表1」所示),取 1224005 心加大鼠’祕’體錯G〜21Gg,實驗翻肛表稍測量義礎 體溫二次,對體溫波動錢扣的大鼠皮下注射娜的啤酒酵母縣. 液麗/kg,注射4小時後再次量測體溫,選用體溫升高lt以上了 - 且升溫相近的大鼠50隻進行實驗,將大鼠隨機均分5組,即喷富 液⑻高偷,偷低繼,安她,細細^、 劑組和空自對驗(如表〗之噴鼻液(_)料轉母雜 溫的影響α,卿)),綠·,騎驗_岭試物滴鼻給華, 每次〇.14ml/kg,10分鐘内滴完,伽分鐘給藥-次,連續給_參 次總給藥體積均机4ml/kg,兩個嘴鼻液(_)組分別給稀釋後 兩組濃度的喷鼻液(滴劑),總給藥量,高劑量組相當於生藥 Ug/kg ’低劑量相當於生藥12 _,安乃近組給予稀釋後的 安乃近注射液’安乃近累計用量為〇. 〇8 g/kg,泰諾退熱口服滴劑 組給泰諾退熱口服滴劑’總給藥量飢14_對乙我氨美紛,* 白對照組給予等體積的生理鹽水,分別於末次的q 5、 時再次測量體溫’實驗結果見表。(注:喷鼻液的劑量按給予的生φ 藥劑量’泰諾退熱口服滴劑_量按所含對乙統 與空白對照組比較*Ρ<〇.()5 **—p<G(n。 . 實驗結果表明:喷鼻液(滴劑),泰諾退熱口服滴劑,安乃近. 注射液滴鼻給_有不囉度的解熱個,與空白對照組比較, 具有顯著性和非f顯著性差異,在三種受試_巾,安乃近的解 熱效果較弱’只在給藥後兩小時才錢著的解熱翻⑽〇5), 16 1224005 噴鼻液高㈣組和與其臨床㈣倍數铜的錢 與空白對照組比較,給藥0.5小2、4 ;:乍用較強 . ^ T勺有非书顯著的解熱 乍用U解熱過程上看泰諾賴後近期效果較好, (滴)作用持續時間較長。 二、喷鼻液(滴)的毒理研究方面: 【實驗材料】 1、喷鼻液(滴劑),每毫升喷鼻液(滴劑)合生藥也物,臨 床以每毫升2g生藥的喷鼻液(滴劑)給藥、小兒每1G公斤體重2滴_ (即約0.1ml)十分鐘内滴完,每十分鐘一次,連續給藥每公斤體重 約0.2g生藥。 2、Wistar大鼠,雌雄兼用體重18〇〜22〇§,由何南醫科大學實 驗動物中心提供。 【方法與結果】 1、急性毒性試驗 取健康大鼠副〜22〇g按體重,性別隨機分為3組,即嘴鼻液(滴籲 劑)高劑量組,低劑量組和空白對照組,每組1〇隻,雌雄各半,實 驗在20 25 C至溫條件下進行,喷鼻液(滴劑)高劑量組滴鼻給予每 毛升3 4g生藥的噴鼻液,低劑量組喷鼻給予每毫升含鉍生藥喷鼻 液’空白對照組滴鼻給予生理鹽水,每次G· lml/kg,1G分鐘内給 凡母10刀知給藥一次,連續給藥1〇次,間隔8小時,然後再重覆 上述給藥過程,累計一日内總給藥量,高劑量組相當於生藥 17 1224005 8g/kg ’低劑量組相當於生藥4g/kg給藥後室溫下飼養,連續觀察 七天,給藥後大鼠的飲水,進食,活動,體重,毛色等均無異常, 詳細情況見下表,七天後將大鼠解剖檢心、肝、脾、肺、腎、胃、 腸、腦、鼻、喉、氣管、支氣管等組織器官,均未見異常改變, 故噴鼻液給大鼠滴鼻給藥8g/kg(相當於生藥的藥)未引起急性毒 性反應,此劑量相當於臨床用量的40倍。 噴鼻液(滴劑)急性毒性試驗結果 器官系統 ------— 給藥後的表現 中樞神經系統及軀體運動 活動自如,對各種刺激的反應無 異常 自主神經系統 瞳孔大小正常 呼吸系統 呼吸平穩,頻率和節律正常,未 見咳嗽哮喘等現象 心血管系統 跳動無異常 胃腸系統 大便成形,無其他異常改變 皮毛 毛色有光澤,皮膚彈性良好,未 ~^^__一_ 見異常 ---—---- 噴鼻液(滴劑)的刺激性試驗 k甩健康大鼠20只,體重18〇〜220g ’隨機分為喷鼻(滴劑)的 組和空白對照,每組10只,雌雄各半,實驗在溫室22±2°C下進行, 、驗^將贺鼻液(滴劑)緩慢滴入大鼠鼻腔,每10分鐘一次,每次 18 1224005 t)斤’連續給藥1岐,貌轉每公㈣能κ含生 nt大既呼吸平穩,呼吸頻率,轉正常,無㈣、哮 而至息專呼吸道不良反應,給藥24小時後解剖大鼠,檢查大谷 -、喉、氣管、支氣管科吸輕膜,均未見充血,铺= 學改變’可靖為喷鼻液(_)伽鼻給藥無她性。、 上述本發明之喷鼻液(_)具有良好的解熱作用,在作強度 ^作用持續_上都·_解鋪安乃近,與進口藥物泰諾退 :口服滴劑侧姻,且無刺激性,按臨床用量_倍(8_生 樂)給大鼠滴鼻未見急性毒性反應,這為其臨床用藥提供了藥理 實驗依據,說明喷鼻液(滴劑)是一個安全性大的醫藥組成物:、 再參閱「表2至表5所示」’係本發明之發燒感冒喷鼻液(滴) 劑療效觀察表。在這些療效觀察表中可看出在不畔齡層使用 下’依不同感f疾病,給予不同的藥劑量,可清楚看出本發明之 發燒感f喷鼻液(滴)劑在患者直接噴(滴)於鼻腔内部,由鼻腔内 部之枯膜吸1後’能在短暫時間上控制住病情,因此在醫療效果 上皆有顯著之醫療效果。 綜上所述本發明以狹葉柴胡、板藍根、大青葉及維生素c之醫 藥組成物,以提取及濾出藥液後,製成可直接噴(滴)於患者之鼻 腔内部,由鼻腔内部之粘膜吸收後,以達治療發燒感冒之疾病, 同時,讓無法吞食藥粒或藥水之患者,提供一極為方便之醫療效 果0 【圖示簡單說明】 19 1224005 圖1,係本發明之發燒感冒喷鼻液(滴)劑之製作流程示意圖。 【表1〜5之簡要說明】 表1,係本發明之發燒感冒喷鼻液(滴)劑對啤酒酵母致熱大鼠體溫 的影響(°C,土SD)示意圖。 表2至表5,係本發明之發燒感冒喷鼻液(滴)劑療效觀察表。Ldn β), indirubin. It also contains inorganic elements such as iron, titanium, manganese, zinc, copper, and cobalt, furnace, code, complex, and arsenic. Indigo-hydrolysis can be changed to indigo and xylofuranose (D-xylo-5-hexulofuranosonic acid). y, 酉 夂 [Pharmacological aspects] Anti-pathogenic microorganism effect, in vitro test of Daqingye decoction on Staphylococcus aureus, Streptococcus aureus, Meningococcus pneumoniae, Streptococcus pneumoniae, typhoid bacteria, E. coli, Epidemic, diphtheria, and dysentery all have some inhibitory effects. Daqingye has inhibitory effect on Japanese encephalitis virus, Yuesi adenovirus, influenza virus, etc. In addition, Daqingye still has the effect of killing Leptospira. [Functions and Indications] Clearing away heat and detoxifying, Liang A eliminates spots. Indications of fever, fever, thirst, fainting, spot rash, soil jk blood ’Θ itch], erysipelas, itchy throat, aphthous ulcer, treatment of moonlight. 4. Vitamin C (Vitamin C) ί2 1224005 [Chemical composition] It is composed of carbon, hydrogen and oxygen. ‘[Pharmacological aspects] Prevent colds, cold symptoms include fever, chills, general weakness, intense coughing, thinness, stuffy nose, headache, joint pain, and so on. Colds are mostly caused by filter pathogens, so your body will be weak. If you get bacterial infection again, it will easily cause serious diseases such as lung inflammation, bronchitis, tonsillitis, and myelitis. [Functions and Indications] Prevent colds, increase resistance, and reduce cold symptoms. Treats colds caused by filtered pathogens. The above medical music composition is extracted, filtered, and extracted separately, and the ingredients contained in each medical composition are extracted and filtered, and then mixed and combined to make it available for spraying (dropping) into the patient. The nasal mucosa absorbs the fever and cold nasal spray (drops), and the preparation process is as follows: The first step is to extract the volatile oil, and 250 ~ 300g Bupleurum chinense is first doubled with the amount of sweet water / and / pack 2 small At the same time, add 4 times more water to decoction, and use the steam steaming method to extract 2ml ~ 2.4W of volatile oil, and then filter out 1000ml ~ 1200ml of liquid medicine, and then use the volatile oil, filtrate and drug residue separately. The container is temporarily stored. In the second step, 120 to 144 g of isatis root and 120 to 144 g of big green leaves are respectively added to seven times the amount of water for 1 hour and then filtered, and the filtered liquid is temporarily stored in a container. The third step is to store the first Step 12 and the second step after extracting or filtering the remaining 13 1224005 medicine residues, and then add _ Wenqian five times the amount of water He Hour, work out the liquid ^ and then add four times the amount of water to cook for 40 minutes, Then the filtrates are combined; ^ The fourth step is to combine the three filtrates and the filtrate, and Ω reduced to the equivalent of liquid to raw music. Then add 95% ethanol to 70% alcohol content; the fifth step, the county's above-mentioned static body office, wealth, current medicine lg; f six steps, then the chest ~ 2.4ml volatile oil and 1 () ~ 12§ Vitamin C is added to the medicinal solution after dissolution, mixed and filtered, and then obtained by dispensing. The above-mentioned medicinal composition is extracted into a spray (drop) nasal preparation, and the fine nasal preparation is not directly damaged by the intestinal Ph value or enzyme, and is absorbed directly from the nasal cavity. Not only avoid the destruction of the first pass of the viscera when oral, but also reduce the toxicity or side effects of the agent on the liver. Lexan is less absorbed in the nasal membrane than π, and Gamma is generally quicker in mouth and mouth. 'For patients with mixed or swallowing drugs _ Qian Tong, _ nasal administration and in the above pharmaceutical composition After having a fever and cold mouth and nose liquid liniment preparation, it has a prostitute effect and safety in the experiments of antipyretic effect and toxicological research, so that it can be used safely when it is used. The antipyretic effect and toxicological research mentioned above are described as follows: 1. The antipyretic effect of nasal spray (drops): [Experimental materials] 1. Each nasal spray (drops) contains 2g of crude drug. The clinical medication 4 is 14 drops per ten kilograms of body weight (about 0.1 ml), which is completed within ten minutes and used 10 times in a row. The cumulative dose per kilogram of body weight is equivalent to about 0.2 g of crude medicine. Before the experiment, a nasal spray will be used. (Drops) diluted to the required drug concentration. 2. Analgin injection, produced by Wuhan Pharmaceutical Factory, batch number 9511104, specification 0.5 g / ml, clinical infants and young children use 20% solution for nasal drops, 2 drops on each side of the nostril, that is, each time When the maximum dosage is about 40 mg, the average weight of infants and young children is calculated as 10 kg. When 44 mg per kg of body weight is administered, Shilin will inject and release Analgin into the required drug concentration. 3. Tylenol antipyretic π liquid drop (mEN〇L children S Ps LIQUID), produced by Johnson & Johnson in the United States, batch number SGM199, each bottle I5πα, each Q.8ml contains 80mg of petaminophen (Acetaminophen) The clinical administration is based on age or body weight, about 0.12 mi per a kilogram of body weight-human administration, that is, about 121,111 amino acids are given. 4 physiological saline, produced by Pingdingshan Pharmaceutical Factory in Henan Province, batch number read. 5 ^ l〇W ^ > S ## t ^ (Themingling ferment liquid for fresh beer), take the fresh beer yeast suspension, evacuate it, take the dregs and centrifuge with physiological saline repeatedly, and discard the supernatant. Then · 5 test methylcellulose is formulated into a cis concentration. 6 Wistar big breasts, weight m ~ · g, provided by Experimental Animal Center of Henan Medical University. [Methods and results] The experiment was performed at room temperature 20 ~ 25 t: Chromium A 卞 / (see Table 1), and 1224005 hearts were added to the rat's mysterious body error G ~ 21Gg. The anus is turned slightly to measure the temperature of the basal basal body twice, and the rats with fluctuating temperature and money were subcutaneously injected with Natto Yeast. Liquid Li / kg, 4 hours after the injection, the body temperature was measured again, and the body temperature was increased by lt or more-and Fifty rats with similar heating temperature were used for experiments. The rats were randomly divided into 5 groups, that is, spraying with liquid-rich stalks, stealing high, stealing, and lowering, and then, she, ^, agent group and air self-examination (as shown in the table below) The effect of nasal fluid (_) on the mother's miscellaneous temperature α, Qing)), green ·, riding test _ Ridge test substance nasal drops to China, each time 0.14ml / kg, finished within 10 minutes, Gamma minutes administration -Times, continuously _ the total dose volume of each time is 4ml / kg, the two oral and nasal fluid (_) groups are given nasal spray (drops) of the two concentrations after dilution, the total dose, high dose The group is equivalent to crude drug Ug / kg 'low dose is equivalent to crude drug 12 _, the Analgin group was given diluted Analgin injection', the cumulative dose of Analgin was 0.08 g / kg, Tylenol fever oral drops Agent group Give Tylenol Antipyretic Oral Drops 'Total dose of hunger 14_ for ethaminophen, * the white control group was given an equal volume of normal saline, and the temperature was measured again at the last q5,' the experimental results are shown in the table . (Note: The dose of nasal spray is based on the amount of raw phi given, and the amount of Tylenol Antipyretic Oral Drops is _ the amount is compared with the control group B and the blank control group. * P < 〇. () 5 ** — p & G (n.. The experimental results show that: nasal spray (drops), Tylenol antipyretic oral drops, An Naijin. Injectable nasal injections give _ a lot of antipyretic, compared with the blank control group, it has significant Significant difference between sex and non-f, in three kinds of test towels, An Najin's antipyretic effect was weaker. 'The antipyretic effect was only two hours after administration. (5)), 16 1224005 Nasal spray high pressure group Compared with its clinical multiples of copper and the blank control group, 0.5, 2, 4, and 4 were given at first use: Stronger at first use. ^ T spoon has a significant non-book antipyretic effect. At first glance, see the short-term effects of Tylenol after antipyretic use. Better, (drops) last longer. Second, the toxicological research of nasal spray (drops): [Experimental materials] 1. Nasal spray (drops), per milliliter of nasal spray (drops) confluence Drugs are also administered clinically in a nasal spray (drops) of 2g crude drug per milliliter, 2 drops per 1G kg of weight in children (ie about 0.1ml), and the drops are completed within ten minutes, one every ten minutes Continuously administer about 0.2g of crude drug per kilogram of body weight. 2. Wistar rats, both male and female, weigh 180-220. § provided by the Experimental Animal Center of Henan Medical University. [Methods and Results] 1. Acute toxicity test for health Rats ~ 22 g were randomly divided into 3 groups according to body weight and gender, that is, high-dose group, low-dose group and blank control group, 10 rats in each group, half male and half female. 20 25 C to warm temperature, nasal spray (drops) in the high-dose group was given nasal spray of 3 4g crude drug per hair liter, and the low-dose group was sprayed with bismuth-containing nasal spray per milliliter of blank control. In the group, physiological saline was administered by nasal drip, each time G · lml / kg, and the mother was given 10 knives once in 1G minutes, 10 times in a row, with an interval of 8 hours, and then repeated the above-mentioned administration process. Total daily dose, high-dose group is equivalent to crude drug 17 1224005 8g / kg 'low-dose group is equivalent to crude drug 4g / kg reared at room temperature after administration, and observed continuously for seven days. Rats drink water, eat, and move after administration. , Weight, hair color, etc. are all normal, see the table below for details. Rats were dissected and examined for heart, liver, spleen, lung, kidney, stomach, intestine, brain, nose, throat, trachea, bronchus and other tissues and organs. No abnormal changes were observed. Therefore, nasal spray was administered to rats by nasal administration of 8g / kg. (Equivalent to crude drugs) Does not cause acute toxicity, this dose is equivalent to 40 times the clinical dose. Results of acute toxicity test of nasal spray (drops) Organ system ------- Performance of central nervous system after administration System and body movement freely, no abnormal response to various stimuli, autonomic nervous system, normal pupil size, normal breathing, stable breathing, normal frequency and rhythm, no cough and asthma, cardiovascular system beating, no abnormal gastrointestinal system stool formation, no other abnormalities Change the fur color and luster, the skin elasticity is good, not ~ ^^ __ 一 _ see abnormality ----------- irritation test of nasal spray (drops) k healthy rats 20 weight, 18 ~ 220g 'Randomly divided into a nasal spray (drops) group and a blank control, 10 in each group, male and female, the experiment was performed at 22 ± 2 ° C in a greenhouse. Drip into rat nasal cavity every 10 Once every 12 to 18,24,005 t) kilograms of continuous administration of 1 qi, the appearance of each male ㈣ can contain nt large nt, both breathing is stable, the breathing frequency is normal, and there is no snoring or wheezing, and the respiratory adverse reactions are special, The rats were dissected 24 hours after the administration, and the light-absorbing membranes of Otani, larynx, trachea, and bronchial department were examined, and no congestion was seen. The above-mentioned nasal spray (_) of the present invention has a good antipyretic effect, and its strength is sustained. The effect is sustained. _Jiepu Anaijin is similar to the imported drug Tylenol: oral drops, and no irritation. According to the clinical dosage _ times (8_ Shengle), no acute toxicity was observed in the rat's nose, which provided a pharmacological experimental basis for its clinical use, indicating that the nasal spray (drops) is a safe medicine Composition: Please refer to "shown in Table 2 to Table 5" again, which is a therapeutic effect observation table of the fever and cold nasal spray (drop) of the present invention. It can be seen in these efficacy observation tables that when used at different ages, different drug doses are given according to different sensations of f, and it can be clearly seen that the fever sensation of the present invention is sprayed directly on patients. (Dripping) inside the nasal cavity. After being sucked by the dead film inside the nasal cavity, the condition can be controlled for a short period of time, so it has significant medical effects in terms of medical effects. In summary, the present invention uses the medical composition of Bupleurum chinense, Isatis indigotica, Daqingye, and vitamin c to extract and filter out the medicinal solution, and then it can be sprayed (dropped) directly into the patient's nasal cavity, and from the inside of the nasal cavity. After the mucous membrane is absorbed, it can treat fever and cold diseases, and at the same time, it can provide a very convenient medical effect for patients who cannot swallow medicine or liquid. [Simplified illustration of the figure] 19 1224005 Schematic diagram of the nasal spray (drop) preparation process. [Brief description of Tables 1 to 5] Table 1 is a schematic diagram of the effect of the fever and cold nasal spray (drop) of the present invention on the body temperature (° C, soil SD) of beer yeast-heated rats. Tables 2 to 5 are observation tables for the efficacy of the fever and cold nasal spray (drops) of the present invention.
20 1224005 >120 1224005 > 1
21 1224005 i8/? +1Γ! r 丨S r ¾ §5/6 s、 5/3 —^! 丨6/321 1224005 i8 /? + 1Γ! R 丨 S r ¾ §5 / 6 s, 5/3 — ^! 丨 6/3
UR Ν «Γ - ϋίλ2 Μ: iyrtTt Μ ±ιτ 4 J:赛: JlllI^ ill 一 2 __3r 4 k纂-# #_η%/12 ±籌 6 51珠鉍e ±無 e ,ί$0 - £、 、5> s zl【z fep |f/2 lig/a 5/2 ft/ 茗 ,0/2 9€ 1!ςπ/2 to 0 骞來;B i^l舲 ,2 3a®>ttWL)»嫌 i?d ί fl· i 一 37 37 1 38*3\ » 4 :gr38 39^-. S β 37一 S6 37*-,e 37 一 | 36' ·£» 道雾 I& 涔^¥1«|鋒7碾^»|失撕|1 薇__潘Hint I雲»恭潯 38· 37 二 »一 0裹# 30· #Ρ·Λ*·»« ^:#_^錄#1| 3a f#·障^__ ^棄氣J;*!丨 39- 39h_T!s!!i!門 391_ϋ ⑷! srsun^Jll^」j-M家濟.虔 WsS;M2’薄»| 审 Ami/12i±lgl4^ 2 * s奉 (3 •卜备丨®!;^:»ί^」!*!*、 ;丨............I丨I丨 :s 4°«#ιι·λ嫌 丨! 4奪簿、声 Is __ δ 39 1 S8 hr ?r 1 丨....^ JODJ sr 3-:«a»J3 §?绘㈣ 3? 37 1-].,,! . 1¾¾ 37 36 -.n S8 36 0S0§S¾着輩·灌 ii^ii …_#和!li„ liii 丨丨 —:_i_i ilili ::...Ητϋ_ :丨 鵁繽#麟||瓣T梁_Η#0ι m 36/ 36 (-』 :^:¾ V: a ;g:^Q5 38, 39 -. 5 3β 3 a” 37 i^JJr 3-aa丨 37」 37 s 38 3? 一 36 36 09 ,:2 :211¾‘ 39上3气 37 1- —8? 热雲1m· 靠露霧論 a^s— $0iswime ~ aM/vw #慨遂产典舞磉Hm-IN^»— 热涔遂米 —^llii叫ί「 M.T£!isMiMliiir^ J!,ni« 丨!热涔,丨 •s讓罐t雜 22 1224005 i 5 |ίγ β s § r 2E1 rUR Ν «Γ-ϋίλ2 Μ: iyrtTt Μ ± ιτ 4 J: Race: JlllI ^ ill a 2 __3r 4 k k- # # _η% / 12 ± raise 6 51 beads bismuth e ± no e, ί $ 0-£, 、 5 > s zl 【z fep | f / 2 lig / a 5/2 ft / 茗, 0/2 9 € 1! Σπ / 2 to 0 骞 来; B i ^ l 舲, 2 3a® > ttWL) » I? D ί fl · i one 37 37 1 38 * 3 \ »4: gr38 39 ^-. S β 37 one S6 37 *-, e 37 one | 36 '· £» Road fog I & 涔 ^ ¥ 1 «| Front 7 Milling ^» | Missing tears | 1 Wei__Pan Hint I Cloud »Gong 浔 38 · 37 Two» One 0 Wrap # 30 · # Ρ · Λ * · »« ^: # _ ^ 录 # 1 | 3a f # · Barrier ^ __ ^ Abandoned air J; *! 丨 39- 39h_T! S !! i! 门 391_ϋ ⑷! srsun ^ Jll ^ 」jM 家 济. Pie WsS; M2 'thin» | review Ami / 12i ± lgl4 ^ 2 * s Feng (3 • Bu Bei 丨 ® !; ^: »ί ^」! *! * 、 ; 丨............ I 丨 I 丨: s 4 ° «# ιι · λλ 丨! 4 Capture book, sound Is __ δ 39 1 S8 hr? R 1 丨 .... ^ JODJ sr 3-: «a» J3 §? Drawing 3? 37 1-]. ,,!. 1¾¾ 37 36 -.n S8 36 0S0§S¾Generation · Gui ii ^ ii… _ # 和! li „liii 丨丨 —: _i_i ilili :: ... Ητϋ_: 丨 鵁 彬 # 麟 || lob T-beam_Η # 0ι m 36/36 (-』: ^: ¾ V: a; g: ^ Q5 38, 39-. 5 3β 3 a ”37 i ^ JJr 3-aa 丨 37 ″ 37 s 38 3? 36 36 09, 2: 2: 211¾ '39 Shang 3 Qi 37 1--8? Hot cloud 1m · Dew fog theory a ^ s— $ 0iswime ~ aM / vw # 慨 Sui Chan Dian Wu 磉 Hm-IN ^ »— 热 涔 涔 米 — ^ llii is called『 MT £! isMiMliiir ^ J!, ni «丨! 涔, 丨 • s let Canister miscellaneous 22 1224005 i 5 | ίγ β s § r 2E1 r
Is 1£:/1 rIs 1 £: / 1 r
IziIzi
feBTfeBT
F 96 s/i 96 fcrF 96 s / i 96 fcr
B M 1 0 β #霧零 2^r 磁It I遂 £»?rB M 1 0 β # 雾 零 2 ^ r Magnetic It I 遂 £ »? R
#NJ 部着潘 #s JUMM. i葚 ♦鷗 I# * i染激酗 .律条 索 m#NJ 部 着 潘 #s JUMM. I 葚 ♦ 鸥 I # * i
II
O m s i c? <N9 h* m tQ.........' Vt* 無 r\s hr 翏!翏 ro Μ ψ〇 iN3 ΙΏ 瓣舉. %O m s i c? ≪ N9 h * m tQ ......... 'Vt * None r \ s hr 翏! 翏 ro Μ ψ〇 iN3 ΙΏ Valve lift.%
II
I 篇_逢 ϋ S3 s s fg ζλ ica 05 1 C〇 認 zji 丨οσChapter I_Feng ϋ S3 s s fg ζλ ica 05 1 C〇 Recognize zji 丨 οσ
L2 QO i aiil.i 1¾ ik»^0 1¾ #11.怜 ¥焉 i^s i.s 1£.,δ ski 讅嬸镳 **# 蜻,·熟 __.黯錄.燐嫌 雲_ 彘»,吩冷讎瓢 β _ _ _ l£ 39 _ 37.L2 QO i aiil.i 1¾ ik »^ 0 1¾ # 11. 焉 ¥ 焉 i ^ s is 1 £., Δ ski 讅 婶 镳 ** # Dragon, · cooked __. 暗 录. 燐 疑云 _ 彘» Phenol, β _ _ _ l £ 39 _ 37.
SB 38 iafe 37 37,SB 38 iafe 37 37,
K 3气 372 3e, 36 39 一 S8 39 38 37 38 30 39 i 39 38 37 i 38 39 39 36 s ¾ 37 37 38 38 37 g 3? 3β S8 3? 38 38 10* 37 38 37 36 3β 37 36 36 36 37 ¾ 3°. 3K ^ 30? 36 3? 3? 36, 36 S6 ¾ m 37 36 s 36 3eb 1K 3 gas 372 3e, 36 39-S8 39 38 37 38 30 39 i 39 38 37 i 38 39 39 36 s ¾ 37 37 38 38 37 g 3? 3β S8 3? 38 38 10 * 37 38 37 36 3β 37 36 36 36 37 ¾ 3 °. 3K ^ 30? 36 3? 3? 36, 36 S6 ¾ m 37 36 s 36 3eb 1
6R —3— Ρ00^ $$Μ»β0 #_瀘涂遢裊療翥 Ρ00 ♦塞震截 β0 鞒漆連涂 ms^ si β0 #鱭遂米媒舞雋截 si«s;..s.g55s-...l^l.a- I*6R —3— Ρ00 ^ $$ Μ »β0 #_ 泸 涂 遢 袅 治 翥 Ρ00 ♦ Plug shock interception β0 lacquer continuous coating ms ^ si β0 # 鲚 米米 舞 隽 interception si« s; ... -... l ^ la- I *
I & — *玲sI & — * lings
If +H_£fIf + H_ £ f
If i+H_#^ Λ* f業 #瓤兹涂汫舞寡β_I錄諍#涔 #鶸逢来籲灞案截 ;έ!ί Ρ00$^^β00 «_浼癲第薄 τί # ··1«- / Μ-ψ .................... aM令W tl - - -1.- ...............»»- - -/.fn» 截薄 藩寒 m 0 0, 嘛»典 _3* 23. 1224005 13^~ s/2 d%l_ 營| g/i s Φ j S/2 一 Α4δ 辦 m'fcH#If i + H _ # ^ Λ * f 业 # 瓤 兹 涂 汫 舞 Wisdom β_I 录 诤 # 涔 # 鶸 逢 来 appeals to the case; έ! Ί Ρ00 $ ^^ β00 «_ 浼 Eagle 第 薄 τί # ·· 1 «-/ Μ-ψ .......... aM order W tl---1.- .............. . »»---/. Fn »Intercepting the Han Dynasty m 0 0, Well» Code_3 * 23. 1224005 13 ^ ~ s / 2 d% l_ Camp | g / is Φ j S / 2 一 Α4δ Office m 'fcH #
IgwiliE: 「Μ T irt # δ/2 15#篠磲 β β rw sf/l 坤r 3¾IgwiliE: 「Μ T irt # δ / 2 15 # 磲 磲 β β rw sf / l Kun r 3¾
Fl g/lFl g / l
FF
Is § ggl ^Is § ggl ^
Jk Μ 3100 41 45 is 50 ω7 42 雕»羚;2Β V rf_T./vrfvv*li <· i / 難wn 43 #«llsrJk Μ 3100 41 45 is 50 ω7 42 Vulture »Antelope; 2B V rf_T./vrfvv*li < · i / 难 wn 43 #« llsr
As l*fill t 1¾ 37 s ?4 45 23 5S 49 41 Μ Jbllt ±輳As l * fill t 1¾ 37 s? 4 45 23 5S 49 41 Μ Jbllt ± 辏
I ±薷 h*ls i iI ± 薷 h * ls i i
I i i i ¥i ±ll 16 12 16 ie 16 16 16 16 12 12: ο 16 le 14 12 s 14 ±1114I i i i ¥ i ± ll 16 12 16 ie 16 16 16 16 12 12: ο 16 le 14 12 s 14 ± 1114
JtJii 14 镎 灣 mwm 58 39JtJii 14 Shaukeiwan mwm 58 39
1C 37 aa 39 g1C 37 aa 39 g
3B S.IMt00^0 IMik舞k鶸 s.s.i -.i#»»· 3.i3B S.IMt00 ^ 0 IMik 舞 k 鶸 s.s.i -.i # »» · 3.i
SB -ρβ,β$ 3a g 33* 38, 39SB -ρβ, β $ 3a g 33 * 38, 39
3CD f4mt¥0 #_kn^JI^裏 Ρ0.β^β ί3CD f4mt ¥ 0 # _kn ^ JI ^ 里 Ρ0.β ^ β ί
1¾ K ^I 1¾ K ¾ 38 jz! 56 ]¾ ¾ #1¾ 儀舞碓靠羹碓1*1 A嬅雄靠钃澹第Λ1¾ K ^ I 1¾ K ¾ 38 jz! 56] ¾ ¾ # 1¾ 仪 舞 碓 羹 碓 1 * 1 A 嬅 雄 钃 澹 钃 澹 第 Λ
im 蠡溪 llilI 3气 37 37 i 38im Xixi llilI 3 gas 37 37 i 38
30D 38 ¾ 38 se 37 37 ¾ 38 3® 3ΰ 37 36 3β 36 S6 37 37 37 38 g mi* 3:0» 3气30D 38 ¾ 38 se 37 37 ¾ 38 3® 3ΰ 37 36 3β 36 S6 37 37 37 38 g mi * 3: 0 »3 gas
Pm0^ #»ϊPm0 ^ # »ϊ
37 jlnAJMMIL 3ϋ lm 逮洚*舞»# 3?_os6*36_ IMt 遂涞批泠_涔篥》 F,a〜37 jlnAJMMIL 3ϋ lm 洚 洚 * 舞 »# 3? _Os6 * 36_ IMt 涞 涞 批 泠 _ 涔 篥" F, a ~
if SI 37 »!»#Ι1Λ# 一¾ 38 3?- 37 ae s 3β 36 3? 3气if SI 37 »!» # Ι1Λ # 一 ¾ 38 3?-37 ae s 3β 36 3? 3
I 10· 3°. 6气 I? 難I 10 · 3 °. 6 gas I? Difficult
I §m 证裹资修 ί$ 蠢 Λ» 截》 1 &0^β *1I §m Certificate repair ί $ stupid Λ »Section 1 & 0 ^ β * 1
I i 24 1224005 >5 fi> lloi/1 E/2 rI i 24 1224005 > 5 fi > lloi / 1 E / 2 r
IfisJ;ss 慶雄 sIfisJ; ss Qingxiong s
M 卡嫵鸯' s ^migM· 3i Μ iM Card 妩 鸯 's ^ migM · 3i Μ i
2Q s 攀 39 302Q s climb 39 30
16 I 3B 全身.不逋 1全身不遽 ζα : 03 03 OB u Γ» m \ta ,3 t& ο» σ» OB 39「姻»*^_^lk 38 37 3?«37· 3B 36 s^*l ^1 _1»1R 1 一1|畢冊It is 18 mwm * #灕.洛舞 m -.ιέ^%» SJl , 用霈㉛確黴 IN**·» C2 _ 洽ί g m a m 0 urns«- 2516 I 3B whole body. No 逋 1 whole body 遽 α: 03 03 OB u Γ »m \ ta, 3 t & ο» σ »OB 39「 「» * ^ _ ^ lk 38 37 3? «37 · 3B 36 s ^ * l ^ 1 _1 »1R 1 一 1 | Bishu It is 18 mwm * # 黎. 洛 舞 m -.ιέ ^%» SJl, use 霈 ㉛definite mold IN ** · »C2 _ ίί gmam 0 urns «-25
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW87114505A TWI224005B (en) | 1998-09-02 | 1998-09-02 | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW87114505A TWI224005B (en) | 1998-09-02 | 1998-09-02 | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI224005B true TWI224005B (en) | 2004-11-21 |
Family
ID=34568099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW87114505A TWI224005B (en) | 1998-09-02 | 1998-09-02 | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI224005B (en) |
-
1998
- 1998-09-02 TW TW87114505A patent/TWI224005B/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488833B (en) | Traditional Chinese medicine preparation possessing efficacy of dispelling wind, ventilating lung, eliminating heat and relieving cough | |
| CN103110730A (en) | Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof | |
| CN101411782A (en) | Pharmaceutical composition for treating acute pharyngitis and preparation method thereof | |
| CN103977314A (en) | Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition | |
| CN105748900A (en) | Traditional Chinese medicine for treating chronic laryngitis and preparation method of traditional Chinese medicine | |
| CN103494962B (en) | Traditional Chinese medicine composition capable of clearing heat and detoxifying | |
| CN104324125B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN110237174A (en) | A kind of eliminating dampness Chinese medicine composition and preparation method thereof for treating cold cough | |
| CN103041030B (en) | Pharmaceutical composition for treating fever with swollen head, as well as preparation method and application thereof | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN102512552A (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN114748603B (en) | Pharmaceutical composition for preventing and treating new coronavirus pneumonia from changing or restoring yang and application thereof | |
| TWI224005B (en) | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same | |
| CN104225200A (en) | Traditional Chinese medicine for treating fluid retention invading heart-lung type cardiac asthma and preparation method thereof | |
| CN104435560B (en) | Alleviate the Chinese medicine composition and preparation method of incision pain after anesthesia disappears | |
| CN103272111A (en) | Traditional Chinese medicine liquor for treating toothache | |
| WO2006094460A1 (en) | A medicine for treating cough and asthma and preparation method thereof | |
| CN102861258B (en) | Drug composition for treating coma, preparation method and application thereof | |
| CN102106999A (en) | Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof | |
| CN102198182A (en) | Medicament for treatment of interstitial pneumonia | |
| CN109106842B (en) | A medicine for stopping smoking and its preparation method | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN101199753B (en) | Oral administration Chinese medicine for treating dryness-heat cough hemoptysis | |
| CN119326825A (en) | A preparation method of the classic prescription Mahuang Decoction | |
| CN107029058A (en) | A kind of Chinese medicine composition for treating chronic pharyngitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiration of patent term of an invention patent |